Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changes.
Elisabeth GjefsenKristina GervinGuro GollLars Christian Haugli BråtenMonica WigemyrHans Christian D AassMaria Dehli VigelandElina SchistadLinda Margareth PedersenAre Hugo PrippKjersti StorheimKaja Kristine SelmerJohn Anker ZwartPublished in: RMD open (2021)
These results suggest that cytokines may play a role in LBP with MCs. The clinical significance of the findings is unknown. MIF strongly contributed to clustering of patients with LBP with MCs and controls, and might be a biomarker for MCs. Ultimately, these results may guide future research on novel treatments for this patient group.